About Edward Hu
Edward Hu is the Vice Chairman of WuXi AppTec and CEO of WuXi Advanced Therapies, with extensive experience in operations management, business development, and financial management.
Known information
Edward Hu is a prominent figure in the biotechnology and pharmaceutical industries, currently serving as the Vice Chairman of WuXi AppTec and the CEO of WuXi Advanced Therapies. He joined WuXi AppTec in 2007 and has played a crucial role in expanding the company’s business on a global scale. Hu has a broad range of experiences, including operations management, new business creation and development, venture investments, mergers and acquisitions, and financial management. Before his tenure at WuXi AppTec, he was the Senior Vice President and Chief Operating Officer at Tanox. He also held managerial and financial positions at Biogen and Merck. Edward Hu holds both an MBA and a Master’s degree in chemistry from Carnegie Mellon University.
About LifeMine Therapeutics
LifeMine Therapeutics is revolutionizing drug discovery by mining genetically-encoded small molecules from the biosphere, utilizing an advanced AI- and genomically-enabled platform.